newsfilter
← Latest News
GlobeNewswire·

AffaMed Therapeutics Announces Merger with EverInsight Therapeutics and Appoints Dayao Zhao, M.D., Ph.D. as CEO

SHANGHAI, China, Oct. 14, 2020 (GLOBE NEWSWIRE) -- AffaMed Therapeutics (“AffaMed”), a biopharmaceutical company focused on developing and commercializing transformative therapeutics to address...